Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1973 1
1978 1
1979 3
1980 3
1981 5
1982 12
1983 19
1984 24
1985 26
1986 27
1987 19
1988 33
1989 33
1990 29
1991 26
1992 32
1993 37
1994 26
1995 29
1996 48
1997 30
1998 44
1999 48
2000 50
2001 44
2002 59
2003 62
2004 52
2005 62
2006 94
2007 72
2008 51
2009 48
2010 29
2011 36
2012 49
2013 26
2014 36
2015 24
2016 37
2017 38
2018 37
2019 22
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

1,422 results
Results by year
Filters applied: . Clear all
Page 1
Carbamazepine.
Alrashood ST. Alrashood ST. Profiles Drug Subst Excip Relat Methodol. 2016;41:133-321. doi: 10.1016/bs.podrm.2015.11.001. Epub 2015 Dec 31. Profiles Drug Subst Excip Relat Methodol. 2016. PMID: 26940169 Review.
This chapter includes the aspects of carbamazepine. The drug is synthesized by the use of 5H-dibenz[b,f]azepine and phosgene followed by subsequent reaction with ammonia. Carbamazepine is generally used for the treatment of seizure disorders and neuropathic pain, it …
This chapter includes the aspects of carbamazepine. The drug is synthesized by the use of 5H-dibenz[b,f]azepine and phosgene followed …
Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
Musetti L, Tundo A, Benedetti A, Massimetti G, Cambiali E, Pergentini I, Del Grande C, Dell'Osso L. Musetti L, et al. Hum Psychopharmacol. 2018 Nov;33(6):e2676. doi: 10.1002/hup.2676. Epub 2018 Oct 12. Hum Psychopharmacol. 2018. PMID: 30311959 Clinical Trial.
OBJECTIVE: This study aims to describe the prescription patterns of the mood stabilizers most commonly used for the treatment of bipolar I and II disorders (lithium, valproate, and carbamazepine) and to analyze the treatment outcomes. ...Polytherapy was prescribed m …
OBJECTIVE: This study aims to describe the prescription patterns of the mood stabilizers most commonly used for the treatment of bipolar
Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Vasudev A, et al. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004857. doi: 10.1002/14651858.CD004857.pub2. Cochrane Database Syst Rev. 2011. PMID: 22161387 Review.
BACKGROUND: Oxcarbazepine, a keto derivative of the 'mood stabiliser' carbamazepine, may have efficacy in the treatment of acute episodes of bipolar disorder. Potentially, it may offer pharmacokinetic advantages over carbamazepine. OBJECTIVES: To review the e …
BACKGROUND: Oxcarbazepine, a keto derivative of the 'mood stabiliser' carbamazepine, may have efficacy in the treatment of acute epis …
A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
Missio G, Moreno DH, Demetrio FN, Soeiro-de-Souza MG, Dos Santos Fernandes F, Barros VB, Moreno RA. Missio G, et al. Trials. 2019 Oct 26;20(1):608. doi: 10.1186/s13063-019-3655-2. Trials. 2019. PMID: 31655626 Free PMC article. Clinical Trial.
BACKGROUND: Treatment of bipolar disorder (BD) usually requires drug combinations. Combinations of lithium plus valproic acid (Li/VPA) and lithium plus carbamazepine (Li/CBZ) are used in clinical practice but were not previously compared in a head-to-head trial. ... …
BACKGROUND: Treatment of bipolar disorder (BD) usually requires drug combinations. Combinations of lithium plus valproic acid (Li/VPA …
Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review.
Giménez A, Pacchiarotti I, Gil J, Murru A, Gomes SP, Pinzón JE, Anmella G, Gómez-Ramiro M, Verdolini N, Valentí M, Goikolea JM, Vieta E. Giménez A, et al. Psychiatr Pol. 2019 Apr 30;53(2):223-244. doi: 10.12740/PP/105906. Epub 2019 Apr 30. Psychiatr Pol. 2019. PMID: 31317955 Free article. English, Polish.
OBJECTIVES: Antiepileptic drugs (AEDs), which are commonly used as a treatment for acute phases and prevention of relapses in bipolar disorder (BD) and schizoaffective disorder (SAD), have been often associated to adverse outcomes in pregnancy and major congenital malforma …
OBJECTIVES: Antiepileptic drugs (AEDs), which are commonly used as a treatment for acute phases and prevention of relapses in bipolar
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C, Heilbronner U, Squassina A. Pisanu C, et al. Mol Diagn Ther. 2018 Aug;22(4):409-420. doi: 10.1007/s40291-018-0335-y. Mol Diagn Ther. 2018. PMID: 29790107 Review.
Bipolar disorder (BD) is a common and disabling psychiatric condition with a severe socioeconomic impact. BD is treated with mood stabilizers, among which lithium represents the first-line treatment. ...On the other hand, genetic information has been included in drug label
Bipolar disorder (BD) is a common and disabling psychiatric condition with a severe socioeconomic impact. BD is treated with mood sta
Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.
Weisler RH. Weisler RH. Expert Rev Neurother. 2005 Sep;5(5):587-95. doi: 10.1586/14737175.5.5.587. Expert Rev Neurother. 2005. PMID: 16162082 Review.
Carbamazepine has a long history in psychiatry and neurology. More recently, carbamazepine extended-release capsules have been approved by the US Food and Drug Administration for the treatment of manic and mixed episodes associated with bipolar I disorder. ..
Carbamazepine has a long history in psychiatry and neurology. More recently, carbamazepine extended-release capsules have been
Extended-release carbamazepine for acute bipolar mania: a review.
Owen RT. Owen RT. Drugs Today (Barc). 2006 May;42(5):283-9. doi: 10.1358/dot.2006.42.5.985635. Drugs Today (Barc). 2006. PMID: 16801991 Review.
In December 2004, an extended-release capsule formulation of carbamazepine was approved by the U.S. Food and Drug Administration for the treatment of acute manic or mixed episodes associated with bipolar I disorder. ...Carbamazepine's most frequ …
In December 2004, an extended-release capsule formulation of carbamazepine was approved by the U.S. Food and Drug Administrati …
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA, Ketter TA, Kalali AH. Nasrallah HA, et al. J Affect Disord. 2006 Oct;95(1-3):69-78. doi: 10.1016/j.jad.2006.04.030. Epub 2006 Jun 15. J Affect Disord. 2006. PMID: 16780960 Review.
There are an increasing number of pharmacologic therapies for bipolar disorder. Two of these agents, the anticonvulsants carbamazepine (CBZ) and valproate (VPA), were first developed over 30 years ago for the treatment of epilepsy, and subsequent studies demonstrate …
There are an increasing number of pharmacologic therapies for bipolar disorder. Two of these agents, the anticonvulsants carbamaze
Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE Jr, McElroy SL. Keck PE Jr, et al. J Clin Psychiatry. 2002;63 Suppl 10:13-7. J Clin Psychiatry. 2002. PMID: 12392348 Free article. Review.
BACKGROUND: Carbamazepine and valproate are used in the treatment of acute bipolar mania and as maintenance treatments for bipolar disorder. ...DATA SYNTHESIS: Although a paucity of data exists from randomized, placebo-controlled trials, carbamazepine
BACKGROUND: Carbamazepine and valproate are used in the treatment of acute bipolar mania and as maintenance treatments for …
1,422 results
Jump to page
Feedback